These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 26363571)

  • 1. Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest.
    Petek BJ; Bravo PE; Kim F; de Boer IH; Kudenchuk PJ; Shuman WP; Gunn ML; Carlbom DJ; Gill EA; Maynard C; Branch KR
    Ann Emerg Med; 2016 Apr; 67(4):469-476.e1. PubMed ID: 26363571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute kidney injury and renal replacement therapy in victims from out-of-hospital cardiac arrest with administration of contrast agent].
    Christ M; Auenmüller KI; Amirie S; Brand M; Sasko BM; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2016 Mar; 27(1):6-14. PubMed ID: 26671252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of gadolinium for arterial interventions.
    Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
    Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Preinterventional Cystatin-Creatinine-Ratio: A Prognostic Marker for Contrast Medium-Induced Acute Kidney Injury and Long-Term All-Cause Mortality.
    Lüders F; Meyborg M; Malyar N; Reinecke H
    Nephron; 2015; 131(1):59-65. PubMed ID: 26287495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C and contrast-induced acute kidney injury.
    Briguori C; Visconti G; Rivera NV; Focaccio A; Golia B; Giannone R; Castaldo D; De Micco F; Ricciardelli B; Colombo A
    Circulation; 2010 May; 121(19):2117-22. PubMed ID: 20439784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial.
    Timal RJ; Kooiman J; Sijpkens YWJ; de Vries JPM; Verberk-Jonkers IJAM; Brulez HFH; van Buren M; van der Molen AJ; Cannegieter SC; Putter H; van den Hout WB; Jukema JW; Rabelink TJ; Huisman MV
    JAMA Intern Med; 2020 Apr; 180(4):533-541. PubMed ID: 32065601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).
    Er F; Nia AM; Dopp H; Hellmich M; Dahlem KM; Caglayan E; Kubacki T; Benzing T; Erdmann E; Burst V; Gassanov N
    Circulation; 2012 Jul; 126(3):296-303. PubMed ID: 22735306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttraumatic contrast-induced acute kidney injury: minimal consequences or significant threat?
    Matsushima K; Peng M; Schaefer EW; Pruitt JH; Kashuk JL; Frankel HL
    J Trauma; 2011 Feb; 70(2):415-9; discussion 419-20. PubMed ID: 21307743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
    Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
    Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
    Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postcontrast Acute Kidney Injury in Pediatric Patients: A Cohort Study.
    McDonald JS; McDonald RJ; Tran CL; Kolbe AB; Williamson EE; Kallmes DF
    Am J Kidney Dis; 2018 Dec; 72(6):811-818. PubMed ID: 30041876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
    Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.